1/33
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Cryoprecipitate antihemophilic factor CRYO
Protein precipitate portion of FFP thawed at 1-6C
Volume 15 ml for single unit and 100ml (pool of 5)
Stored at -18C (Cannot be frozen)
Shelf life 1 year
CRYO contents
vWF 80-120 units
Fibrinogen >150mg
Factor VIII >80IU
Factor XIII 40-60IU
Fibronectin
CRYO vWF
80-120 units
CRYO fibrinogen
>150mg
CRYO Factor VIII
>80 IU
CRYO Factor XIII
40-60IU
CRYO prep
Thaw at 30-37C
Store 6 hours at 20-24C after that (4 hours) if pooled
Cannot be re-frozen
Transfuse within 4 - 6 hours
CRYO indications
Hypofibrinogenemia <200 mg/dL
Dysfibrinogenemia
Uremic bleeding not responsive to DDAVP
Factor XIII deficiency
vWF / Hemophilia 2nd line
CRYO contraindications
vWF conc are available
Hemophilia A conc available
Rh type irrelevant, but ABO compatibility preferred
CRYO dosing
Standard Dose: 10 units (=2 pooled units) repeat test for response
30 minutes to thaw and pool
Outdate after thawing; 4-6 hours, store at room temp
Platelets
Apheresis
1 single donor platelet = 6 pooled
5 days outdate at room temp, rotation/ agitation
Test for bacteria
ABO type specific
Plastic permeability
Random donor platelets
50-65 ml
Minimum 5.5 × 10^10 platelets per bag
Single unit should raise platelet count by 5,000-10,000/ul
If pooled must be given within 4 hours
Single donor platelets
Volume 180-250ml but can be reduced
6-10units of random donor platelets conc
1 ½ - 2 ½ hour apheresis time
3 ×10^11 platelets per unit
Raise platelet count by 30,000 - 50,000
Cold storage platelets
Same as single donor
14 days outdate
Store at 1-6C without agitation
Platelet indications
Thrombocytopenia or active platelet related bleeding
Bone marrow failure, chemo, cardiopulmonary bypass
Dysfunctional platelet disorders
Prophylaxis on anti-platelet meds
Platelet contraindications
TTP platelet destruction
Microangiopathic processes and PTP
Heparin induced thrombocytopenia
Platelet count >100k/ul without dysfunction
Cirrhosis / splenomegaly
Unrelated bleeding
Transfusion night before procedure
Factors affecting platelet transfusion effectiveness
Splenomegaly
Hyperthermia
Sepsis
Allo-platelet antibodies
Auto-platelet antibodies
Splenomegaly
platelet sequestration - decreased platelet increment
Hyperthermia / Spesis
decreased platelet survival
Allo-platelet antibodies
Anti HLA markedly decreased platelet increment; requires HLA matched platelets to get satisfactory platelet transfusion increment
Auto-platelet antibodies ITP
no platelet increment response
24 hour post-infusion count
if no incremental rise, then this signifies a problem
Could be accelerated usage as in DIC or could be another extenuating factor as seen above
1 hour post transfusion count
if no incremental rise, then the patient probably has platelet antibodies, splenomegaly, sepsis, or hyperthermia present
Platelet refractoriness
A repeat failure to achieve homeostasis or expected increment count
Associated with poor post transfusion platelet count on 2 separate occasions + DIC, MAHA, TTP, etc
Granulocytes
Mobilize the donor with corticosteroids ± G-CSF
Volume 250-300ml
> 1.0X10^10 granulocytes
20-50ml RBCs
3×10^11 platelets
Hematocrit 10%
Granulocytes pedigree
Pedigreed donors, emergency release before IDMs are preformed
Extend to 30 day testing
Granulocytes storage
Room temp 20-24 without agitation
Shelf life 24 hours
Granulocytes considerations
Must be irradiated, ABO compatible
Must NOT be leukocyte reduced
can cause severe transfusion RXN
Granulocytes indications
Culture proven infection G-ve
NOT responsive to antimicrobial therapy
Neutropenia
Expected bone marrow recovery
Transplant patients
Neonatal sepsis
Hereditary neutrophil defects
Granulocytes contraindications
Prophylaxis in non-infected patients
Whole blood
Operational setting, trauma, massive transfusion, military, autologous transfusion
Volume 450-500ml
Storage 1-6C
Shelf life 21-35 days
Whole blood components
200ml of RBCs
250ml plasma, WBCs, platelets, and anticoagulant
Whole blood cirumstances
ABO identical or low titer O positive whole blood LTOWB in trauma setting
Prothrombin Complex Concentrate
Assayed for Factors IX and II
Contains Factors II, VII, IX, and X - Vitamin K Dependent
Small volume highly concentrated
Used for factor IX deficiency (Hemophilia B) and Factor II deficiency